Jacobs Levy Equity Management’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-185,076
Closed -$918K 951
2024
Q1
$918K Buy
+185,076
New +$1.18M ﹤0.01% 730
2023
Q4
Sell
-292,593
Closed -$2.03M 968
2023
Q3
$2.03M Buy
292,593
+112,572
+63% +$679K 0.01% 554
2023
Q2
$1.04M Sell
180,021
-951,008
-84% -$6.15M 0.01% 694
2023
Q1
$7.19M Buy
1,131,029
+32,541
+3% +$310K 0.04% 334
2022
Q4
$12.9M Buy
1,098,488
+472,507
+75% +$5.75M 0.09% 248
2022
Q3
$7.41M Buy
+625,981
New +$9.14M 0.06% 314

Other funds holding ALHC

Jacobs Levy Equity Management's ALHC Position: Q2 2024 in Review

Jacobs Levy Equity Management sold out of Alignment Healthcare (ALHC) in Q2 2024, closing a stake of 185,076 shares — an estimated $918K sold.

Jacobs Levy Equity Management first reported a position in ALHC in Q3 2022 and held it in 6 quarters. The position peaked at $12.9M in Q4 2022. 118 funds tracked by Wall St. Rank hold ALHC as of Q2 2024.

  • Jacobs Levy Equity Management reported no remaining Alignment Healthcare position as of Q2 2024 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 185,076 Alignment Healthcare shares in Q2 2024, an estimated $918K.
  • Jacobs Levy Equity Management first reported a position in Alignment Healthcare in Q3 2022 and held it in 6 quarters.
  • Jacobs Levy Equity Management's Alignment Healthcare position peaked at $12.9M in Q4 2022.
  • 118 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2024.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2024, filed 14 Aug 2024.